Get the Stockscreener App
23.06
6.07%
-1.49
Sionna Therapeutics Inc stock is traded at $23.06, with a volume of 249.25K.
It is down -6.07% in the last 24 hours and up +34.70% over the past month.
Sionna Therapeutics Inc is a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for cystic fibrosis (CF) patients by developing novel medicines that normalize the function of the cystic fibrosis transmembrane conductance regulator (CFTR) protein to deliver clinically meaningful benefit to CF patients. CF is a progressive and life-threatening genetic disease caused by inherited mutations in the CFTR gene, which heads to insufficient CFTR function. The Company is managed as one operating segment focused on the research and development of cystic fibrosis therapies.
See More
Previous Close:
$24.55
Open:
$24.93
24h Volume:
249.25K
Relative Volume:
1.25
Market Cap:
$1.02B
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-10.34%
1M Performance:
+34.70%
6M Performance:
+55.81%
1Y Performance:
+0.00%
1-Day Range:
$21.70
$25.00
1-Week Range:
$21.70
$26.48
52-Week Range:
$7.255
$26.50
Sionna Therapeutics Inc Stock (SION) Company Profile
Name
Sionna Therapeutics Inc
Sector
Industry
Phone
617-819-2020
Address
21 HICKORY DRIVE, SUITE 500, WALTHAM
Compare SION with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SION
Sionna Therapeutics Inc
|
23.06 | 1.12B | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Sionna Therapeutics Inc Stock (SION) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-04-25 | Initiated | Guggenheim | Buy |
| Mar-04-25 | Initiated | Stifel | Buy |
| Mar-04-25 | Initiated | TD Cowen | Buy |
Sionna Therapeutics Inc Stock (SION) Latest News
Tick level data insight on Sionna Therapeutics Inc. volatility2025 Institutional Moves & Fast Moving Market Watchlists - Newser
Sionna Therapeutics Inc. stock prediction for this weekWeekly Profit Summary & Free Weekly Watchlist of Top Performers - Newser
Pattern recognition hints at Sionna Therapeutics Inc. upsideJuly 2025 Action & Free Long-Term Investment Growth Plans - Newser
Price momentum metrics for Sionna Therapeutics Inc. explainedWeekly Trade Analysis & Risk Controlled Daily Trade Plans - Newser
What institutional flow reveals about Sionna Therapeutics Inc.July 2025 Intraday Action & Daily Volume Surge Trade Alerts - Newser
What momentum shifts mean for Sionna Therapeutics Inc.2025 Price Momentum & Fast Gain Stock Trading Tips - Newser
What the charts say about Sionna Therapeutics Inc. todayGap Up & Safe Capital Allocation Plans - Newser
Custom strategy builders for tracking Sionna Therapeutics Inc.Weekly Market Report & High Yield Stock Recommendations - Newser
Real time scanner hits for Sionna Therapeutics Inc. explainedPortfolio Update Summary & AI Forecasted Stock Moves - Newser
Quantitative breakdown of Sionna Therapeutics Inc. recent moveWeekly Investment Recap & Weekly Watchlist of Top Performers - Newser
Will Sionna Therapeutics Inc. outperform during market ralliesBreakout Watch & Growth Oriented Trade Recommendations - khodrobank.com
Top chart patterns to watch in Sionna Therapeutics Inc.July 2025 Fed Impact & Accurate Buy Signal Notifications - Newser
Ridloff Elena, CFO, sells Sionna (SION) shares for $240k - Investing.com
Sionna Therapeutics shares fall 3.78% intraday after Raymond James initiates at Strong Buy. - AInvest
How to build a custom watchlist for Sionna Therapeutics Inc.Portfolio Profit Report & High Yield Equity Trading Tips - Newser
Combining price and volume data for Sionna Therapeutics Inc.July 2025 Levels & Low Risk Entry Point Guides - Newser
RBC Capital Initiates Sionna Therapeutics at Sector Perform With $22 Price Target - MarketScreener
Sionna Therapeutics Inc. recovery potential after sell offTrade Entry Report & Fast Exit and Entry Strategy Plans - Newser
Best data tools to analyze Sionna Therapeutics Inc. stockTrade Volume Summary & Reliable Price Breakout Alerts - Newser
Is Sionna Therapeutics Inc. on track to beat earningsIPO Watch & Pattern Based Trade Signal System - khodrobank.com
Visual analytics tools that track Sionna Therapeutics Inc. performanceQuarterly Portfolio Report & Real-Time Volume Analysis - Newser
What’s next for Sionna Therapeutics Inc. stock priceQuarterly Market Review & Technical Confirmation Alerts - Newser
Trend analysis for Sionna Therapeutics Inc. this weekTrade Volume Summary & Growth Focused Entry Point Reports - Newser
Why Sionna Therapeutics Inc. stock attracts strong analyst attentionInsider Selling & Accurate Buy Signal Alerts - Newser
Will Sionna Therapeutics Inc. outperform the marketMarket Risk Summary & Weekly High Potential Stock Alerts - Newser
Can Sionna Therapeutics Inc. outperform in the next rallyJuly 2025 Action & Accurate Intraday Trade Tips - khodrobank.com
Risk vs reward if holding onto Sionna Therapeutics Inc.Market Performance Report & Community Shared Stock Ideas - Newser
Detecting support and resistance levels for Sionna Therapeutics Inc.Weekly Market Report & Weekly Top Gainers Alerts - Newser
How moving averages guide Sionna Therapeutics Inc. tradingIPO Watch & Real-Time Chart Pattern Alerts - Newser
Can Sionna Therapeutics Inc. sustain its profitability2025 Market WrapUp & AI Based Buy/Sell Signal Reports - khodrobank.com
Sionna Therapeutics Inc. stock outlook for YEARJuly 2025 Spike Watch & Low Risk High Win Rate Picks - Newser
Can Sionna Therapeutics Inc. expand into new markets2025 Retail Activity & Daily Profit Maximizing Trade Tips - khodrobank.com
Sionna Therapeutics Inc. Enters Reversal Setup in Weekly Charts getLinesFromResByArray error: size == 0 - thegnnews.com
Full technical analysis of Sionna Therapeutics Inc. stockPortfolio Gains Summary & Daily Price Action Insights - Newser
RSI Divergence May Trigger a Bounce in Sionna Therapeutics Inc. getLinesFromResByArray error: size == 0 - 강소기업뉴스
Sentiment analysis tools applied to Sionna Therapeutics Inc.Portfolio Performance Summary & Fast Moving Trade Plans - Newser
How institutional ownership impacts Sionna Therapeutics Inc. stockJuly 2025 Technicals & Verified Swing Trading Watchlists - Newser
Sionna Therapeutics Inc Stock (SION) Financials Data
There is no financial data for Sionna Therapeutics Inc (SION). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
Sionna Therapeutics Inc Stock (SION) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Ridloff Elena | CFO & Head of Corp. Dev. |
Aug 29 '25 |
Sale |
25.18 |
748 |
18,835 |
47,368 |
| Cloonan Michael | President & CEO |
Aug 26 '25 |
Option Exercise |
6.11 |
17,574 |
107,377 |
564,917 |
| Cloonan Michael | President & CEO |
Aug 27 '25 |
Option Exercise |
6.11 |
7,426 |
45,373 |
554,769 |
| Cloonan Michael | President & CEO |
Aug 26 '25 |
Sale |
24.96 |
17,574 |
438,647 |
547,343 |
| Cloonan Michael | President & CEO |
Aug 27 '25 |
Sale |
25.01 |
7,426 |
185,714 |
547,343 |
| Ridloff Elena | CFO & Head of Corp. Dev. |
Aug 28 '25 |
Sale |
25.97 |
16,098 |
418,065 |
48,116 |
| Ridloff Elena | CFO & Head of Corp. Dev. |
Aug 26 '25 |
Sale |
25.13 |
3,700 |
92,981 |
67,832 |
| Ridloff Elena | CFO & Head of Corp. Dev. |
Aug 27 '25 |
Sale |
25.10 |
3,618 |
90,812 |
64,214 |
1.75%
1.11%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):